Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain, Lipids, vol.34, issue.S1, pp.34-39, 1999. ,
DOI : 10.1007/BF02562227
Nutrition and cognitive function, Brain and Development, vol.19, issue.3, pp.165-70, 1997. ,
DOI : 10.1016/S0387-7604(96)00560-8
Omega-3 fatty acids and cardiovascular disease: A case for omega-3 index as a new risk factor, Pharmacological Research, vol.55, issue.3, pp.217-240, 2007. ,
DOI : 10.1016/j.phrs.2007.01.013
Unsaturated Fatty Acids Esterified in 2-Acyl-1-Lysophosphatidylcholine Bound to Albumin Are More Efficiently Taken up by the Young Rat Brain than the Unesterified Form, Journal of Neurochemistry, vol.28, issue.3, pp.59-1110, 1992. ,
DOI : 10.1016/0006-291X(90)91708-Z
Preferential incorporation of sn- 2 lysoPC DHA over unesterified DHA in the young rat brain, Am J Physiol, vol.267, pp.1273-1279, 1994. ,
Preferential Transfer of 2-Docosahexaenoyl-1-Lysophosphatidylcholine Through an In Vitro Blood-Brain Barrier Over Unesterified Docosahexaenoic Acid, Journal of Neurochemistry, vol.28, issue.1, pp.72-338, 1999. ,
DOI : 10.1046/j.1471-4159.1999.0720338.x
URL : https://hal.archives-ouvertes.fr/hal-00524636
Acyl and phosphoryl migration in lysophospholipids: importance in phospholipid synthesis and phospholipase specificity, Biochemistry, vol.21, issue.8, pp.1743-1750, 1982. ,
DOI : 10.1021/bi00537a007
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat, Biochem J, pp.345-61, 2000. ,
Synthesis of acetyl, docosahexaenoyl-glycerophosphocholine and its characterization using nuclear magnetic resonance, Lipids, vol.51, issue.12, pp.1333-1337, 1999. ,
DOI : 10.1007/s11745-999-0486-1
Method for preparing acetyl,docosahexaenoylglycerophosphocholine and use thereof for the delivery of polyunsaturated fatty acids, p.68413, 2008. ,
DHA Metabolism: Targeting the Brain and Lipoxygenation, Molecular Neurobiology, vol.37, issue.5???6, pp.48-51, 2010. ,
DOI : 10.1007/s12035-010-8131-7
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894371
Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells, J Lipid Res, vol.38, pp.1571-1582, 1997. ,
Robust Docosahexaenoic Acid-Mediated Neuroprotection in a Rat Model of Transient, Focal Cerebral Ischemia, Stroke, vol.40, issue.9, pp.3121-3126, 2009. ,
DOI : 10.1161/STROKEAHA.109.555979
Brain-Targeting Form of Docosahexaenoic Acid for Experimental Stroke Treatment: MRI Evaluation and Anti-Oxidant Impact, Current Neurovascular Research, vol.8, issue.2, pp.95-102, 2011. ,
DOI : 10.2174/156720211795495349
BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET-ACTIVATING FACTOR (PAF-ACETHER), Annals of the New York Academy of Sciences, vol.123, issue.1, pp.119-137, 1981. ,
DOI : 10.1111/j.1749-6632.1981.tb29727.x
Mediators of Inflammation, Annual Review of Immunology, vol.1, issue.1, pp.335-359, 1983. ,
DOI : 10.1146/annurev.iy.01.040183.002003
Platelet activating factor in pulmonary pathobiology, Clin Chest Med, vol.10, pp.107-118, 1989. ,
Phosphatidylcholines en tant que modulateurs de l'activité du facteur d'activation plaquettaire, p.58149 ,